The Latest Cardiac and Vascular News
– First-of-its-kind steerable delivery system designed for left atrial appendage (LAA) occluder to seal the LAA in people who are at increased risk of stroke due to atrial fibrillation – New delivery system works with Abbott’s leading Amplatzer Amulet™ LAA Occluder device to enable better access to the LAA and […]
Agreement Expands Access to Cardea SOLO™ Digital Health Solution for Early Atrial Fibrillation Detection and Diagnosis BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc. (“Cardiac Insight” or the “Company) is a healthcare innovator specializing in wearable cardiac sensors and proprietary software that automatically analyzes electrocardiogram (ECG) data to detect arrythmias, including atrial fibrillation. […]
− Phase 3b Open-Label Study Showed Treatment with Patisiran Achieved Rapid and Sustained Reduction in Serum TTR Levels in hATTR Amyloidosis Patients with Polyneuropathy Progression Following Orthotopic Liver Transplant – − Additional Results from Pre-specified Patient Subgroups Analysis Included with Encore Presentation of HELIOS-A Phase 3 Study of Investigational Vutrisiran […]
TORRANCE, Calif., June 4, 2021 /PRNewswire/ — Heart-Valve-Surgery.com, a leading patient advocacy group for patients with heart valve disease, today launched the first phase of an end-to-end digital platform for patient awareness, patient education and patient enrollment specific to clinical trials. The new platform – which leverages novel algorithms and technologies – was […]
SUZHOU, China, June 4, 2021 /PRNewswire/ — Peijia Medical Limited signed a memorandum of strategic cooperation with China Resources Pharmaceutical Commercial Group Medical Devices Co., Ltd. on June 2. Going forward, the two parties will collaborate intensively on the commercialization of TAVR products, ultimately providing more Chinese medical staff and patients with better quality […]
Vancouver, BC, Canada, June 03, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on June 3, 2021 in Vancouver, B.C. (the “Meeting”). At the Meeting, […]
– Abbott has the capacity and supply to support increased demand for mechanical circulatory support (MCS) devices following Medtronic’s decision to stop the global distribution and sale of the Medtronic HeartWare™ ventricular assist device (HVAD) – Access to MCS devices are critical for advanced heart failure patients and can improve […]
– Company Developing Support Program for Current HVAD Patients – Medtronic Coordinating with Global Regulators to Assure Patient Access to Left Ventricular Assist Devices DUBLIN, June 3, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, is stopping the distribution and sale of the Medtronic HVAD™ System. This morning, the […]
– Joseph Loscalzo, M.D., Ph.D., appointed chairman of the board – Ionis founder and Executive Chairman Stanley T. Crooke, M.D., Ph.D., retires from the board – Breaux B. Castleman retires from the board – Allene M. Diaz appointed to the board CARLSBAD, Calif., June 2, 2021 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today […]
Issuance of Its Newest U.S. Patent Will Strengthen Anavex’s Compounds Intellectual Property Portfolio NEW YORK, June 03, 2021 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s […]
